Poland· PL-100375205

Fibryga

A fibrinogen, human product containing fibrinogenum humanum, registered in Poland by Octapharma (IP) SPRL. The same ATC class is registered in 11 of our 19 countries.

ATC B02BB01

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fibrinogenum humanumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Fibrinogen, human is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BB01 (fibrinogen, human), each read from that country’s own register.

This record: Poland, from URPL (Poland)
7 of them publish a price we can compare per daily dose

Search fibrinogen, human products by name

Fibrinogen, human · ATC B02BB01

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fibrinogen, human costs, country by country.

Normalised to the WHO defined daily dose (5 g), the median price runs from $2.30 in Czechia to $2694.05 in Switzerland — a ×1171 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Fibrinogen, human · price per daily dose (5 g)

USD · FX 28 Sept 2026

CH Switzerland$2694.05
CZ Czechia$2.30

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Fibrinogenum humanum
Manufacturer: Octapharma (IP) SPRL
Country: Poland (PL)
ATC code: B02BB01
ATC class: Fibrinogen, human
Defined daily dose: 5 g, P
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 1

gtin
05909991339388

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for fibrinogen, human.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check fibrinogen, human against other medicines How interaction checks work

Fibrinogen, human · interactions on record

2 records

2 severe

Most severe, free to view

CarfilzomibL01XG02severe
CarfilzomibL01XX45severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fibrinogen, human in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fibrinogen, human products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Fibclot, Fibryga
Belgium · Fibclot, Fibryga
Bulgaria · Fibryga, Хемокомплетан P
Cyprus · Fibryga, Riastap
Czechia · Fibryga, Haemocomplettan P
Germany · Fibclot, Fibryga
Denmark · Fibclot, Fibryga
Estonia · Fibryga
Spain · Fibclot, Fibryga
Finland · Fibclot, Fibryga
France · Clottafact, Fibryga
United Kingdom (Northern Ireland) · Fibclot, Fibryga
Greece · Fibclot, Riastap
Croatia · Fibryga
Hungary · Fibclot, Fibryga
Ireland · Fibryga, Riastap
Iceland · Fibryga, Riastap
Italy · Fibriclotte, Fibryga
Lithuania · Fibryga
Luxembourg · Fibclot, Fibryga
Latvia · Fibryga
Malta · Fibryga, Riastap
Netherlands · Fibclot, Fibryga
Norway · Fibclot, Fibryga
Portugal · Fibryga, Haemocomplettan
Romania · Fibryga, Haemocomplettan P
Sweden · Fibclot, Fibryga
Slovenia · Fibrema, Prufibry
Slovakia · Fibryga, Riastap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ed39bcb7-30a3-440a-b079-4e7cf737ce7e
GET /v1/drugs/ed39bcb7-30a3-440a-b079-4e7cf737ce7e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań i infuzji",
  "source": "urpl",
  "strength": "1 g",
  "packaging": "05909991339388 ¦ Lz ¦ 123672\n1 butelka 1 g proszku ¦ 1 urządzenie  do rekonstytucji nextaro ¦ 1 fiolka 50 ml rozpuszczalnika",
  "substance": "Fibrinogenum humanum 1 g",
  "common_name": "Fibrinogenum humanum",
  "pl_product_id": "100375205",
  "pozwolenie_nr": "24152",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about fibrinogen, human.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console